Ill. Admin. Code tit. 77, § 661.610 - Responsibilities of Medical Care Facilities
a) All medical care facilities shall provide
written information to all parents, legal guardians or caregivers before the
newborn hearing screening is administered. The written information shall
include:
1) Purpose and benefits of the
hearing screening;
2) Description
of typical auditory development;
3)
Description of the procedures used for hearing screening;
4) Risk factors for hearing loss;
5) Factors that could result in a referral
for further hearing screening; and
6) Importance of timely follow-up for hearing
testing and intervention.
b) After completion of the newborn hearing
screening, medical care facilities shall provide to parents, legal guardians,
or caregivers, orally and in writing, the following information:
1) Time, date, screening technology and
individual-ear screening results for the final screening session prior to
discharge; and
2) Follow-up plan of
care, including the coordination of follow-up screening or diagnostic
appointments and service locations.
c) The medical care facility shall maintain
written documentation of the newborn hearing screening in the newborn, infant
or child's medical record, including the following information:
1) Time, date, screening technology and
individual-ear screening results for the final screening session prior to
discharge;
2) Individual
administering each screening test;
3) Follow-up plan of care, including the
coordination of follow-up screening or diagnostic appointments and service
locations; and
4) Documentation of
screening refusal, if applicable.
d) Newborn hearing screening shall be
performed by an individual who is supervised by a licensed healthcare
professional (recommended to be a licensed audiologist per 2019 Joint Committee
on Infant Hearing Statement). The supervising healthcare professional and
screener shall be trained in the following areas:
1) Anatomy and physiology of the
ear;
2) Nature of responses being
measured;
3) Patient and
non-patient factors that influence responses;
4) Hearing screening procedures;
5) Documentation of results;
6) Type of screening equipment to be
used;
7) Operation of the screening
equipment;
8) Time frames for
screening;
9) Provision of results
to the parents, legal guardian or caregiver, the primary medical care provider,
and the Department;
10)
Confidentiality requirements;
11)
Communicating accurate and appropriate information;
12) The plan of care if the newborn or infant
passed the hearing screening; and
13) The plan of care if the newborn or infant
did not pass the hearing screening.
e) A medical care facility shall identify a
primary and secondary liaison to the EHDI Program at the Department.
f) A medical care facility shall identify, no
later than January 1, 2023, the items listed below and shall report any changes
thereafter, within 7 days, to the Department:
1) primary and/or secondary EHDI
liaison;
2) hearing screening
protocol; and/or
3) hearing
screening equipment.
g)
A medical care facility shall inform the Department no less than 30 days before
any changes related to the outsourcing of newborn hearing screening
services.
h) A medical care
facility shall designate a manager or coordinator employed by the facility who
is responsible for the oversight of newborn hearing screening services. The
manager or coordinator shall be a licensed healthcare professional. The manager
or coordinator shall be responsible for the following:
1) Documentation of medical care facility
EHDI policy and protocols;
2)
Maintenance, operation, and replacement of the hearing screening equipment
within the equipment manufacturer's guidance;
3) Documentation of a hearing screening plan
to ensure the continuation of hearing screening when the equipment is out of
service for greater than 48 hours;
4) Training and supervision of newborn
hearing screening personnel, including retraining and competency monitoring of
newborn hearing screening personnel;
5) Monitoring reporting to the Department;
and
6) Medical facility EHDI data
management.
i) A medical
care facility shall maintain newborn hearing screening equipment that is
approved by the Food and Drug Administration for Newborn Hearing Screening and
meets the following requirements:
1) Screening
technology that measures a physiologic response; is implemented with objective
response criteria; uses a procedure that measures the status of the peripheral
auditory system and is highly correlated with auditory function; and is
approved for newborn hearing screening; and
2) Screening methodology that detects, at a
minimum, any unilateral or bilateral hearing losses equal to or greater than
35dB HL. The methodology used should have a false-positive rate and no less
than 1% and no greater than 4%. For this purpose, false positive rate means the
proportion of newborns or infants without hearing loss who are identified
incorrectly by the screening process as having significant hearing
loss.
j) Medical care
facilities shall calibrate hearing screening equipment in the timeframe and
manner recommended by the manufacturer. Calibration should occur annually or
more frequently per manufacturer guidelines. Newborn hearing screening
equipment per manufacturer guidance.
k) A medical care facility shall report to
the Department when equipment is out of service for greater than 48
hours.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.